Skip to main content

Table 1 Children characteristics

From: Physiological effects of invasive ventilation with neurally adjusted ventilatory assist (NAVA) in a crossover study

Child 1 2 3 4 5 6
Gender M M M F F F
Age (mo) 3 13 4 10 6 11
Weight (kg) 5.7 8.9 7.0 6.0 5.8 7.0
Cardiopathy AVSD VSD with pulmonary stenosis tetralogy of Fallot atrial septal defect coarctation of the aorta pulmonary atresia with VSD
Cardiopulmonary bypass duration (min) 96 83 130 48 0 130
Time between PICU entry and study (hours) 20 7 20 4 5 7
Baseline cardiac index (L/min.m2) 2.00 2.85 1.93 2.60 2.75 1.85
Milrinone (mcg/kg/min) 0.9 0.5 0.3 0.5 0 0.5
Adrenaline (mcg/kg/min) 0 0 0 0 0 0.05
ScvO2 (%) 64 63 52 82 68 52
Perfusion index (%) 0.31 3.65 0.60 3.62 1.90 0.87
Random order CV then NAVA NAVA then CV CV then NAVA CV then NAVA NAVA then CV NAVA then CV
  1. All children were receiving morphine 0.5 mg per kilo per day. All, except the 2 first, were receiving midazolam 40 micrograms per kilo per hour
  2. AVSD atrioventricular septal defect, VSD ventricular septal defect, NAVA neurally adjusted ventilatory assist, CV conventional ventilation, ScvO2: central venous oxygen saturation